A Double Blind, Within Patient, Placebo Controlled Trial to Assess the Efficacy of Juvista (Avotermin) in Conjunction With Scar Revision Surgery for the Improvement of Disfiguring Scars. (Revise)

NCT00742443 Phase 3 COMPLETED

This trial is to determine whether Juvista can prevent scar formation or improve the appearance of scars following scar revision surgery. The trial will involve comparing Juvista to placebo.

Details

Lead sponsor	Renovo
Phase	Phase 3
Status	COMPLETED
Enrolment	350
Start date	2008-12
Completion	2011-02

Conditions

• Cicatrix

Interventions

• Juvista (avotermin)
• Juvista (avotermin)
• Juvista (avotermin)

Primary outcomes

• Global Scar Comparison Scale as assessed by an Independent Clinical Scar Assessment Panel using photographs of the treated scars. — 12 months post surgery

Countries

United States, Denmark, France, Germany, Hungary, Italy, Latvia, Poland, Spain, United Kingdom